Company page
Adma Biologics Inc
Adma Biologics Inc, trading under the ticker ADMA, is a public company based in America with a market capitalization of approximately $1.92 billion. The company focuses on developing and manufacturing specialty biologics for the treatment of infectious diseases. Adma Biologics aims to address unmet medical needs through its innovative products and therapies.

- Ticker
- ADMA:NASDAQ
- Asset type
- Stock
- Market cap
- $2.09B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD